华安医药生物股票发起式A(022690)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
| 结算备付金 |
785,319.33 |
761,740.75 |
623,487.37 |
| 存出保证金 |
304,118.11 |
329,087.54 |
27,690.18 |
| 交易性金融资产 |
730,638,977.03 |
1,014,183,260.15 |
339,982,187.47 |
| 其中：股票投资 |
730,638,977.03 |
1,012,365,086.56 |
339,982,187.47 |
| 债券投资 |
- |
1,818,173.59 |
- |
| 资产支持证券投资 |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
| 应收证券清算款 |
8,952,290.89 |
30,227,991.86 |
- |
| 应收利息 |
- |
- |
- |
| 应收股利 |
- |
- |
56,153.93 |
| 应收申购款 |
7,009,853.14 |
2,345,242.49 |
9,142,499.86 |
| 其他资产 |
- |
- |
- |
| 资产总计 |
817,178,059.85 |
1,171,459,572.84 |
379,053,911.55 |
| 负 债 |
| 短期借款 |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
| 应付证券清算款 |
15,843,019.61 |
- |
3,560,211.67 |
| 应付赎回款 |
5,975,329.77 |
9,156,134.02 |
15,242,217.22 |
| 应付管理人报酬 |
705,565.54 |
1,139,463.23 |
273,416.19 |
| 应付托管费 |
117,594.23 |
189,910.53 |
45,569.41 |
| 应付销售服务费 |
64,653.76 |
140,271.86 |
42,575.28 |
| 应付交易费用 |
- |
- |
- |
| 应交税费 |
9.74 |
- |
- |
| 应付利息 |
- |
- |
- |
| 应付利润 |
- |
- |
- |
| 其他负债 |
927,170.22 |
1,858,306.60 |
350,542.65 |
| 负债合计 |
23,633,342.87 |
12,484,086.24 |
19,514,532.42 |
| 所有者权益 |
| 实收基金 |
554,019,187.28 |
733,348,714.02 |
217,505,539.64 |
| 未分配利润 |
239,525,529.70 |
425,626,772.58 |
142,033,839.49 |
| 所有者权益合计 |
793,544,716.98 |
1,158,975,486.60 |
359,539,379.13 |
| 负债及所有者权益总计 |
817,178,059.85 |
1,171,459,572.84 |
379,053,911.55 |
微信公众号
证券之星APP
基本资料
